Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model (Q36501207)
Jump to navigation
Jump to search
scientific article published on 9 November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model |
scientific article published on 9 November 2012 |
Statements
1 reference
Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model (English)
1 reference
Craig A Elmets
1 reference
Deepali Kurundkar
1 reference
Ritesh K Srivastava
1 reference
Sandeep C Chaudhary
1 reference
Levy Kopelovich
1 reference
Mohammad Athar
1 reference
1 reference
1 reference
Identifiers
1 reference